I agree with most posters here ... it is very hard to sugar-coat the decision handed down on Friday.
@DocMcstuffins was certainly correct, the FDA wanted a RCT, rightly or wrongly. Unfortunately the FDA is being
super cautious with Stem Cells (I'm being very kind here), or perhaps they are being something else. Time will tell.
After taking in the CC, I will actually consider BUYing more. Why?
Simply put ... we may well be looking at an easier and shorter trial ... and these patients may actually be fairly easy to enrol
because there is no other therapy available. Then, in theory, we will have both the kids and adults covered.
This whole trial may not run anywhere as long as people are currently suggesting ... even DocMc ... but we will see.
MSB may not be as 'dead in the water' as some are suggesting. So, I will hold and probable buy.
Good luck all
- Forums
- ASX - By Stock
- MSB
- Ann: Update on BLA for Graft Versus Host Disease
Ann: Update on BLA for Graft Versus Host Disease, page-765
-
-
- There are more pages in this discussion • 253 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.010(0.69%) |
Mkt cap ! $1.667B |
Open | High | Low | Value | Volume |
$1.46 | $1.49 | $1.44 | $3.472M | 2.379M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | $1.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 5440 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12398 | 1.460 |
2 | 19558 | 1.455 |
5 | 49977 | 1.450 |
5 | 102249 | 1.445 |
2 | 30389 | 1.440 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 5440 | 3 |
1.470 | 22187 | 2 |
1.475 | 84389 | 3 |
1.480 | 118230 | 9 |
1.485 | 96793 | 8 |
Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online